Medutest result on a Wuxi dulaglutide lot lands 2.0 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.
Analytics in 2025
Page 11 of 11 of this archive, newest first.
Everything on the page, in the order a chemist would read it
The purity figure is the least informative line on a well-constructed certificate and the only line most buyers read.
Independent analysis puts a SSA survodutide lot at 97.1%, against 96.4% on the certificate
The result is unremarkable. What the report omits is not.
Medutest result on a Nantong semaglutide lot lands 3.0 points below the supplier’s figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Independent analysis puts a QSC exenatide lot at 97.5%, against 96.7% on the certificate
The supplier has not disputed the finding. It has not explained the gap either.
The retest date and the expiry date are not the same document
We asked twenty companies three questions about stability data and print every answer, refusal and non-response.
The question no chromatogram has ever answered
Every certificate circulating in this market answers a question about molecules. Almost none answers a question about organisms, pyrogens, or the integrity of the seal.
Medutest result on a Hangzhou dulaglutide lot lands 3.0 points below the supplier’s figure
The result is unremarkable. What the report omits is not.